Dr. An-Wen Chan is a Mohs surgeon and a clinical epidemiologist with recognized expertise in clinical trial quality, biases, and methods. He has published extensively in leading medical journals, and chairs the international SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) initiative to improve the quality of clinical trial protocols. Organizations and medical journals from around the world have endorsed the SPIRIT guidelines as part of their clinical trial policies. Dr. Chan has also served as a Special Advisor to the Clinical Trials Unit of the Canadian Institutes of Health Research. He helped coordinate the World Health Organization's International Clinical Trials Registry Platform in Geneva and continues to serve on its advisory board.
In addition, Dr. Chan has clinical and research interests in the skin problems of solid organ transplant patients. He directs a specialized transplant dermatology clinic dedicated to skin cancer, infections, and other skin conditions in this immunosuppressed patient population. Dr. Chan also studies the epidemiology and innovative treatment of high-risk skin cancers to help reduce their incidence and impact in transplant patients.
DPhil, Public Health, University of Oxford, 2003
MD, University of Calgary, 2000
Research integrity and transparency
Clinical trial methodology and biases